Gene therapy biotech Homology Medicines files for a $100 million IPO – Nasdaq
NasdaqGene therapy biotech Homology Medicines files for a $100 million IPONasdaqHomology Medicines, a preclinical biotech developing a gene therapy delivery platform for rare diseases, filed on Friday with the SEC to raise up to $100 million in an init… Continue reading
